<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04687280</url>
  </required_header>
  <id_info>
    <org_study_id>2019-24b</org_study_id>
    <nct_id>NCT04687280</nct_id>
  </id_info>
  <brief_title>Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules</brief_title>
  <acronym>CHIC MultiA</acronym>
  <official_title>Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules in Cirrhotic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The detection and diagnosis of hepatocellular carcinoma is a public health issue. MRI is the&#xD;
      most sensitive examination for diagnosis and especially hypervascularization in the arterial&#xD;
      phase.&#xD;
&#xD;
      Several studies have shown that MRI multiphase arterial sequences are superior to single&#xD;
      phase to capture the arterial phase. The purpose of this study is to compare arterial&#xD;
      enhancement sensibilities between multi and single phase sequences.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 22, 2009</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">October 27, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>arterial enhancement</measure>
    <time_frame>1 year</time_frame>
    <description>significant arterial enhancement present in one of the three phases of multiphasic arterial time compared to all other arterial phases or single phase</description>
  </primary_outcome>
  <enrollment type="Actual">153</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>non interventional</intervention_name>
    <description>non interventional, study on data</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient followed up for cirrhosis with discovery of a suspicious CHC nodule during imaging&#xD;
        monitoring&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient included in CHIC study with histology of hepatocellular carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  nodules already treated by chimioembolization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 26, 2020</study_first_submitted>
  <study_first_submitted_qc>December 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>December 22, 2020</last_update_submitted>
  <last_update_submitted_qc>December 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

